Monoclonal Antibodies to Fibroblast Growth Factor Receptor 2 Effectively Inhibit Growth of Gastric Tumor Xenografts

201072 citationsJournal Articlebronze Open Access

Authors

Anti-FGFR2 mAbs GAL-FR21 and GAL-FR22 have potential for the treatment of gastric and other tumors.

Published in: Clinical Cancer Research

Volume 16, Issue 23, pp. 5750-5758

Field-Weighted Citation Impact: 1.72